SCHEMBL7604529

SCHEMBL7604529

CC(=NO)c1ccccc1NC(=O)c1cccc(S(=O)(=O)Nc2ccc(Cl)cc2)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 10/20 0.66
KMT2A Q03164 10/20 0.66
MAPT P10636 5/20 0.56
ADORA3 P0DMS8 1/20 0.51
SLC6A3 Q01959 1/20 0.51
POLB P06746 1/20 0.51
SMN1; SMN2 Q16637 4/20 0.50
GAA P10253 2/20 0.50
KDM4E B2RXH2 1/20 0.50
DUSP3 P51452 1/20 0.50
BLM P54132 1/20 0.50
PTPN5 P54829 1/20 0.50
PTPN11 Q06124 1/20 0.50
MCL1 Q07820 1/20 0.50
TP53 P04637 1/20 0.50
THRB P10828 1/20 0.50
LMNA P02545 3/20 0.48
HTT P42858 2/20 0.48
MAPK1 P28482 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7450127 0.86 MEN1 (0.80) MEN1KMT2AMAPTPOLBTP53
SCHEMBL7449268 0.86 MEN1 (0.68) MEN1KMT2AMAPTADORA3SLC6A3
SCHEMBL27181012 0.83 LMNA (0.62) MEN1KMT2AMAPTADORA3SLC6A3
SCHEMBL7513013 0.81 MEN1 (0.59) MEN1KMT2AMAPTADORA3SLC6A3
SCHEMBL4098366 0.80 MEN1 (0.67) MEN1KMT2AADORA3SLC6A3POLB
SCHEMBL30926863 0.79 MEN1 (0.59) MEN1KMT2AMAPTADORA3SLC6A3
SCHEMBL27181090 0.79 MEN1 (0.59) MEN1KMT2AMAPTADORA3SLC6A3
SCHEMBL7505369 0.78 MEN1 (0.56) MEN1KMT2AMAPTADORA3SLC6A3
SCHEMBL6720181 0.78 MEN1 (0.85) MEN1KMT2AMAPTPOLBTP53
SCHEMBL13870858 0.78 MEN1 (0.82) MEN1KMT2APOLBSMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001098274-A2 SULPHONAMIDE DERIVATIVES CELLTECH CHIROSCIENCE LIMITED (GB) 2001-12-27 WO disclosed